Die Gesamtkosten für die Behandlung von Karzinomatose in der Türkei variieren je nach Ihrem spezifischen Behandlungsplan. Eine ärztliche Konsultation kostet 190 €, ein MRT mit Kontrastmittel und eine CT des Brustkorbs kosten 1.900 €, und die zytogenetische Untersuchung in Kombination mit Omentektomie und Lymphadenektomie ist mit 13.800 € bepreist. Der Behandlungsplan wird nach einer umfassenden Bewertung durch medizinische Fachkräfte festgelegt.
| Türkei | Österreich | Spanien | |
| Hyperthermische intraperitoneale Chemotherapie (HIPEC) | von $22,500 | von $40,000 | von $25,000 |
Dr. Eda Tanrikulu belegte den 3. Platz in der türkischen Facharztprüfung für medizinische Onkologie und leitet die Krebsbehandlung am Anadolu Medical Center.
Dr. Solak ist auf die Behandlung verschiedener Krebsarten spezialisiert, darunter Brust-, Eierstock- und Lungenkrebs, und verfügt über eine umfangreiche Ausbildung am Krebsinstitut der Hacettepe-Universität.
Prof. Peker hat über 400 Operationen bei Bauchspeicheldrüsen- und Magenkrebs durchgeführt und ist im Hisar Hospital Intercontinental auf hepatopankreatobiliäre Chirurgie spezialisiert.
Dr. Banu Atalar ist Fachärztin für Strahlentherapie (Türkei, 2004). Sie ist seit 2018 Professorin an der Acibadem MAA University und seit 2026 klinisch am Anadolu Medical Center tätig. Ihre Ausbildung absolvierte sie an den Universitäten Istanbul und Cerrahpaşa. 2011 schloss sie ein klinisches Forschungsstipendium an der Stanford University in stereotaktischer Radiochirurgie ab. Ihr Schwerpunkt liegt auf Tumoren des ZNS, des Thorax und des Gastrointestinaltrakts. Rund 75 % ihrer Behandlungen entfallen auf SRS (stereotaktische Radiochirurgie) und MR‑geführte adaptive SRS.
Zu ihren Auszeichnungen zählen der ASCO IDEA Award (2004), der IASLC International Mentorship Award (2018) und H.FACR (2025). Sie hat 72 internationale, peer‑reviewte Publikationen. Zu ihren Leitungsfunktionen zählen die Präsidentschaft der Türkischen Gesellschaft für Radioonkologie (2025–27) und der Vorsitz des ESTRO National Societies Committee (2024–27). Sie war Mitglied des ASCO Resource‑Stratified Guidelines Committee (2013–18) sowie der RSS‑Tagungs- und Nominierungsausschüsse. Sie organisierte nationale Kongresse (2023, 2025) und war als eingeladene Referentin auf großen Fachkongressen vertreten.
Specialized treatments for carcinomatosis in Turkey revolve around cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Leading JCI-accredited centers in Istanbul use robotic da Vinci systems and multidisciplinary tumor boards. These protocols treat advanced peritoneal spread from ovarian, colorectal, and gastric cancers with high precision.
Bookimed Expert Insight: Case volume is the most reliable quality signal for this complex procedure. While many Turkish centers offer oncology, only a few like Anadolu Medical Center or Memorial Göztepe perform 400+ specialized gastric or pancreatic surgeries. High-volume teams generally achieve better recovery results because they maintain dedicated peritoneal ICU units. For the best value, look for packages at Liv Hospital Ulus or Memorial that bundle these intensive ICU stays with the surgery price.
Patient Consensus: Patients emphasize that the specific experience of the surgical team matters more than hospital branding. They recommend verifying the official tumor board review and checking imaging accuracy before traveling for the procedure.
Turkish hospitals maintain Western-equivalent quality for carcinomatosis by merging high surgical volumes with international certifications. Centers like Anadolu Medical Center affiliate with institutions like Johns Hopkins to implement American standards. Surgeons utilize the da Vinci robotic system for precise cytoreductive procedures while following strict ESMO and JCI clinical protocols.
Bookimed Expert Insight: While many countries offer HIPEC, Turkish oncology packages frequently include longer post-operative observation than basic international requirements. For instance, Liv Hospital Ulus provides 5 hospital nights and 6 hotel days within their $21,000 package. This extended recovery period is vital for managing the complex nutritional and fluid needs following peritoneal surface malignancy surgery.
Patient Consensus: Patients note that success depends on finding centers with high-volume peritoneal experience. They often find that private hospitals in Turkey offer more personal communication and faster response times than public systems in Western Europe.
Selecting a Turkish clinic for carcinomatosis requires verifying JCI accreditation and a multidisciplinary tumor board. Prioritize centers using cytoreductive surgery and HIPEC protocols. Expert surgeons should hold international certifications. These facilities must maintain advanced intensive care units for complex post-operative recovery management.
Bookimed Expert Insight: Patient data shows a significant expertise gap between general oncology centers and HIPEC specialists. Dr. Suleyman Tumen at Büyük Anadolu Hospitals offers over 25 years of specialized experience. This tenure often leads to more precise resectability assessments. While packages range from $21,000 to $31,000, the higher-end options at Memorial Göztepe Hospital typically cover more complex, multi-organ surgical involvement.
Patient Consensus: Patients emphasize choosing surgeons based on their specific annual case volume rather than hospital branding. They note it is vital to confirm the hospital has a robust blood bank and dedicated stoma care teams before traveling.
Turkish specialists prepare personalized carcinomatosis plans through a remote medical record review. Surgeons evaluate recent imaging files and pathology reports to assess cytoreduction feasibility. This process confirms eligibility for procedures like hyperthermic intraperitoneal chemotherapy (HIPEC) before travel begins within Joint Commission International-accredited facilities.
Bookimed Expert Insight: Top-tier centers like Anadolu Medical Center utilize multidisciplinary tumor boards to refine plans. While some packages cost around $21,000, others reach approximately $30,800 for complex cases. High-volume hospitals performing over 65,000 annual operations often provide more comprehensive staging before surgery begins.
Patient Consensus: Patients note that sending large DICOM imaging files is better than written summaries. Plan your arrival for fresh re-staging scans to avoid surprises during the actual procedure.
Evaluate carcinomatosis success through progression-free survival (PFS) and overall survival (OS) metrics. Request specific data on the Peritoneal Cancer Index (PCI). This score measures cancer spread before Cytoreductive Surgery (CRS) and HIPEC. High-volume Turkish JCI-accredited centers track these outcomes to optimize survival rates.
Bookimed Expert Insight: While survival metrics are vital, look for surgeons with specific international diplomas. Dr. Hakan Teoman Yanar at Liv Hospital Ulus holds a European Board of Surgery honorary diploma. Experts with over 15 years experience often achieve better cytoreduction results. These specialists frequently use the da Vinci robotic system for higher precision. Packages in Turkey often range from $21,000 to $31,000 for these complex procedures.
Patient Consensus: Patients note that understanding the PCI score was crucial for managing expectations. They emphasize that clear communication about post-surgical recovery timelines helped them prepare better.